ITEMS IN AFP WITH KEYWORD:
A 47-year-old patient presents for a routine physical examination. The patient does not have a history of colorectal cancer, inflammatory bowel disease, or adenomatous polyps or a family history of colorectal cancer. The patient's body mass index is 29 kg per m2, and the A1C level at their last visi...
Screening colonoscopy findings define the future risk of colorectal cancer and the need for repeat screening. The U.S. Multi-Society Task Force on Colorectal Cancer updated recommended follow-up intervals after screening colonoscopy in average-risk individuals.
Following a high-quality colonoscopy (adequate bowel preparation, full visualization, and high rates of detection by the colonoscopist), patients at average risk with no neoplasm found on examination had the same rate of developing colorectal cancer or dying from it in the 10- to 17-year interval co...
Computed tomography colonography performs well for colorectal cancer screening. Long-term studies are needed to demonstrate its impact on patient morbidity and mortality, as well as to determine the risks, benefits, and costs.
Aug 15, 2020 Issue
Colorectal Cancer Screening: ACP Guidance Statements [Practice Guidelines]
The American College of Physicians developed a consensus statement for colorectal cancer screening of average-risk adults based on their review of six independent guidelines and supporting evidence.
Aug 15, 2020 Issue
Colorectal Cancer Screening: BMJ Rapid Recommendation [Practice Guidelines]
Colorectal cancer (CRC) screening recommendations vary because the underlying evidence is low quality, with few screening methods evaluated by randomized trials. The BMJ/MAGIC Group performed a systematic review based on 15-year CRC risk models to compare screening options.
Mailed outreach significantly increases rates of colorectal cancer screening, with four tests needing to be mailed to screen one person.
The use of aspirin, NSAIDs, and oral anticoagulants has no clinically important effects on the positive predictive value of FIT in a screening population.
Key clinical questions and their evidence-based answers directly from the journal's content, written by and for family physicians.
Daily low-dose aspirin can be offered to patients older than 50 years for colon cancer prevention.